Cargando…
MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL
BACKGROUND: While aberrant DNA methylation is a characteristic feature of tumor cells, our knowledge of how these DNA methylation patterns are established and maintained is limited. DNA methyltransferases and ten-eleven translocation methylcytosine dioxygenases (TETs) function has been found altered...
Autores principales: | Poole, Candace J., Lodh, Atul, Choi, Jeong-Hyeon, van Riggelen, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604319/ https://www.ncbi.nlm.nih.gov/pubmed/31266538 http://dx.doi.org/10.1186/s13072-019-0278-5 |
Ejemplares similares
-
DNMT3B overexpression contributes to aberrant DNA methylation and MYC-driven tumor maintenance in T-ALL and Burkitt’s lymphoma
por: Poole, Candace J., et al.
Publicado: (2017) -
Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 Inhibition
por: Poole, Candace J., et al.
Publicado: (2018) -
Induced hepatic stem cells maintain self-renewal through the high expression of Myc coregulated by TET1 and CTCF
por: Wang, Chen, et al.
Publicado: (2022) -
MYC—Master Regulator of the Cancer Epigenome and Transcriptome
por: Poole, Candace J., et al.
Publicado: (2017) -
Early Expression of Tet1 and Tet2 in Mouse Zygotes Altered DNA Methylation Status and Affected Embryonic Development
por: Qi, Qi, et al.
Publicado: (2022)